Pages that link to "Item:Q8388"
Jump to navigation
Jump to search
The following pages link to Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) (Q8388):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Taisheng Li (1st author of DOI 10.1080/22221751.2020.1735265) (Q8389) (← links)
- Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) (Q8394) (← links)
- Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395) (← links)
- Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8396) (← links)
- Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) (Q8397) (← links)
- Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) (Q8398) (← links)
- Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) (Q8399) (← links)
- Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8400) (← links)
- Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401) (← links)
- Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402) (← links)
- Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403) (← links)
- Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) (Q8404) (← links)
- Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405) (← links)
- Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406) (← links)
- Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) (Q8407) (← links)
- Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8408) (← links)
- Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8409) (← links)
- Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8410) (← links)
- Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8411) (← links)
- Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) (Q8412) (← links)
- Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8413) (← links)
- Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414) (← links)
- Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) (Q8415) (← links)
- Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8416) (← links)
- Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) (Q8417) (← links)
- Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) (Q8418) (← links)
- Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) (Q8419) (← links)
- Zhou P, et al, Nature (2020) cited as Ref 1 in 10.1080/22221751.2020.1735265 (Q8421) (← links)
- Huang C, et al, Lancet (2020) cited as Ref 2 in 10.1080/22221751.2020.1735265 (Q8422) (← links)
- Chen N, et al, Lancet (2020) cited as Ref 3 in 10.1080/22221751.2020.1735265 (Q8423) (← links)
- Wang D, et al, JAMA (2020) cited as Ref 4 in 10.1080/22221751.2020.1735265 (Q8424) (← links)
- Li Q, et al, N Engl J Med (2020) cited as Ref 5 in 10.1080/22221751.2020.1735265 (Q8425) (← links)
- Chan JF, et al, Lancet (2020) cited as Ref 6 in 10.1080/22221751.2020.1735265 (Q8426) (← links)
- Yu P, et al, J Infect Dis (2020) cited as Ref 7 in 10.1080/22221751.2020.1735265 (Q8427) (← links)
- Holshue ML, et al, N Engl J Med (2020) cited as Ref 8 in 10.1080/22221751.2020.1735265 (Q8428) (← links)
- Kim JY, et al, J Korean Med Sci (2020) cited as Ref 9 in 10.1080/22221751.2020.1735265 (Q8429) (← links)
- Silverstein WK, et al, Lancet (2020) cited as Ref 10 in 10.1080/22221751.2020.1735265 (Q8430) (← links)
- Stoecklin SB, et al, Euro Surveill (2020) cited as Ref 11 in 10.1080/22221751.2020.1735265 (Q8431) (← links)
- Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, Zhonghua Liu Xing Bing Xue Za Zhi. (2020) cited as Ref 12 in 10.1080/22221751.2020.1735265 (Q8432) (← links)
- Frat JP, et al, N Engl J Med (2015) cited as Ref 13 in 10.1080/22221751.2020.1735265 (Q8433) (← links)
- Branson RD, et al, Respiratory care equipment (1995) cited as Ref 14 in 10.1080/22221751.2020.1735265 (Q8434) (← links)
- Zhao H, et al, Crit Care (2017) cited as Ref 15 in 10.1080/22221751.2020.1735265 (Q8435) (← links)
- Cortegiani A, et al, Crit Care (2019) cited as Ref 16 in 10.1080/22221751.2020.1735265 (Q8436) (← links)
- Stephan F, et al, Respir Care (2017) cited as Ref 17 in 10.1080/22221751.2020.1735265 (Q8437) (← links)
- Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, Zhonghua Liu Xing Bing Xue Za Zhi (2020) cited as Ref 18 in 10.1080/22221751.2020.1735265 (Q8438) (← links)
- Hui DS, et al, Eur Respir J (2019) cited as Ref 19 in 10.1080/22221751.2020.1735265 (Q8439) (← links)
- Kang H, et al, Respir Care (2019) cited as Ref 20 in 10.1080/22221751.2020.1735265 (Q8440) (← links)
- Chikata Y, et al, Respir Care (2016) cited as Ref 21 in 10.1080/22221751.2020.1735265 (Q8441) (← links)
- National Health Commission cited as Ref 1 in DOI: 10.1080/22221751.2020.1735265 (Q8442) (← links)
- World Health Organization cited as Ref 2 in DOI: 10.1080/22221751.2020.1735265 (Q8443) (← links)